ClinicalTrials.gg
RecruitingNCT07618104Updated Jun 1, 2026

Pornography Abstinence and Nocturnal Erections in Adult Men

An observational study in Erection; Incomplete, sponsored by Efforia, Inc. Recruiting at 1 site in United States. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Efforia, Inc · Observational

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
100
Ages
18 Years and older
Sex
Male
01

Study summary

The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.

Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.

Read the detailed description

This single-arm, real-world observational study evaluates the association between pornography abstinence and changes in nocturnal penile tumescence, sexual function, and psychosocial outcomes in adult men.

During an initial baseline phase, participants continue their typical pornography use while collecting objective nocturnal erection data and completing baseline questionnaires. Participants then enter a 30-day abstinence period, during which they attempt to refrain from pornography use. Abstinence adherence is self-reported, with lapses logged as observational data rather than protocol violations.

Nocturnal penile tumescence is assessed nightly using the Adam Sensor, a non-invasive wearable device that measures changes in penile circumference during sleep. Additional outcomes are assessed using validated questionnaires administered at baseline and at weekly intervals. The study is exploratory and signal-detecting in nature and is not designed to establish causality.

Study Design

Study Type: Observational

Study Design: Single-arm, within-participant comparison

Time Perspective: Prospective

Masking: None (Open Label)

Primary Purpose: Health outcomes assessment / signal detection

Additional information can be found at the study recruitment landing page here: https://app.efforia.com/30-day-tv-abstinence-challenge/

02

Conditions studied

  • Erection; Incomplete

Keywords

  • Erection
  • Men's health
03

In context

Lead sponsor

Efforia, Inc is the lead sponsor of 25 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adult men who are interested in evaluating how a 30-day period of pornography abstinence may affect their sexual health, nocturnal erections, and overall well-being. Participants are self-selected volunteers who report current or recent pornography use, are able to attempt abstinence for the duration of the study, and are willing to use a non-invasive wearable device to collect nocturnal penile tumescence data and complete electronic questionnaires. The study population reflects a real-world, consumer-based sample rather than a clinically diagnosed population.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult males of legal age of consent
  • Willingness to attempt pornography abstinence
  • Ability to use a wearable device during sleep
  • Ability to complete electronic surveys
  • Willingness to purchase the study device

Exclusion criteria

Exclusion Criteria:

  • Have a history of significant sexual dysfunction requiring active medical treatment
  • Have current or uncontrolled mental health disorders
  • Have a history of addictive behaviors that may be exacerbated by abstinence
  • Are undergoing hormonal therapy or treatment affecting sexual function
  • Are experiencing unstable interpersonal or relationship stressors
  • Have significant concerns about privacy related to sexual health data
  • Have cultural or religious considerations that could cause distress
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Single Arm longitudinal where participants act as their own control

    Single Arm longitudinal where participants act as their own control

    Behavioral: Pornography Abstinence

Interventions

  • BehavioralPornography Abstinence

    Participants will attempt to abstain from all pornography use for 30 consecutive days. Any deviations from abstinence are self-reported and logged for contextual analysis.

06

What researchers measure

Primary outcomes

  1. Change in Nocturnal Penile Tumescence

    Measure: Adam Sensor - Nocturnal Erection Tracking Description: Objective measurement of nocturnal penile tumescence, Frequency/Time nocturnal erections per night

    Time frame: Baseline Day to Day 38

Secondary outcomes

  1. Change in Erectile Function

    Measure: International Index of Erectile Function (IIEF-15) Scale Range: 5-75 (higher scores indicate better erectile and sexual function) Description: Assesses erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction.

    Time frame: Baseline to Day 38 after intervention

  2. Change in Sexual Desire

    Measure: Sexual Desire Inventory-2 (SDI-2) Scale Range: 0-112 (higher scores indicate greater sexual desire) Description: Measures both dyadic and solitary sexual desire.

    Time frame: Baseline to Day 38 after intervention

  3. Change in Pornography Consumption Patterns

    Measure: Weekly Pornography Consumption Survey (custom self-report) Scale: Frequency and duration categories (ordinal) Description: Tracks self-reported pornography use and abstinence adherence.

    Time frame: Baseline to Day 38 after intervention

  4. Change in Mood, Energy, and Emotional Well-Being

    Measure: Weekly Self-Assessment Check-In (custom) Scale: 1-10 Likert-type scales (higher scores indicate more favorable states) Description: Assesses perceived mood, mental clarity, energy level, and emotional resilience.

    Time frame: Baseline to Day 38 after intervention

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2025 (actual). Primary completion is estimated for Sep 2026, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2026
First posted
Jun 1, 2026
StartActual
Sep 22, 2025
Primary completionEst.
Sep 22, 2026
CompletionEst.
Sep 22, 2026
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07618104
Lead sponsor
Efforia, Inc
Responsible party
Sponsor
First posted
Jun 1, 2026
Start date
Sep 22, 2025
Primary completion
Sep 22, 2026 (estimated)
Completion
Sep 22, 2026 (estimated)
Last update
Jun 1, 2026

Study contacts

Matthew Amsden
Contact
help@efforia.com
(646) 679-2479

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion